Evidence map›Paper›PMID 32341787›Full record

Observational studyOpen heart2020

Prognostic impacts of changes in left ventricular ejection fraction in heart failure patients with preserved left ventricular ejection fraction.

Akiomi Yoshihisa, Yu Sato, Yuki Kanno, Mai Takiguchi, Tetsuro Yokokawa, Satoshi Abe, Tomofumi Misaka, Takamasa Sato, Masayoshi Oikawa, Atsushi Kobayashi and 3 more

Abstract readObservational Study
In one paragraph

Observational study in Open heart, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Akiomi YoshihisaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.ORCID 0000-0001-5574-6617
Yu SatoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Yuki KannoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Mai TakiguchiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Tetsuro YokokawaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Satoshi AbeDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Tomofumi MisakaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Takamasa SatoDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Masayoshi OikawaDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Atsushi KobayashiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Takayoshi YamakiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Hiroyuki KuniiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.
Yasuchika TakeishiDepartment of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: It has been reported that recovery of left ventricular ejection fraction (LVEF) is associated with better prognosis in heart failure (HF) patients with reduced EF (rEF). However, change of LVEF has not yet been investigated in cases of HF with preserved EF (HFpEF). Methods and results: Consecutive 1082 HFpEF patients, who had been admitted to hospital due to decompensated HF (EF >50% at the first LVEF assessment at discharge), were enrolled, and LVEF was reassessed within 6 months in the outpatient setting (second LVEF assessment). Among the HFpEF patients, LVEF of 758 patients remained above 50% (pEF group), 138 patients had LVEF of 40%-49% (midrange EF, mrEF group) and 186 patients had LVEF of less than 40% (rEF group). In the multivariable logistic regression analysis, younger age and presence of higher levels of troponin I were predictors of rEF (worsened HFpEF). In the Kaplan-Meier analysis, the cardiac event rate of the groups progressively increased from pEF, mrEF to rEF (log-rank, p<0.001), whereas all-cause mortality did not significantly differ among the groups. In the multivariable Cox proportional hazard analysis, rEF (vs pEF) was not a predictor of all-cause mortality, but an independent predictor of increased cardiac event rates (HR 1.424, 95% CI 1.020 to 1.861, p=0.039). Conclusion: An initial assessment of LVEF and LVEF changes are important for deciding treatment and predicting prognosis in HFpEF patients. In addition, several confounding factors are associated with LVEF changes in worsened HFpEF patients.

Indexed as

Stroke VolumeVentricular Function, LeftAgedAged, 80 and overAge FactorsBiomarkersCause of DeathComorbidityDisease ProgressionFemaleHeart FailureHumansMaleMiddle AgedPrognosisProspective StudiesBiomarkersTroponin Icardiac remodellingheart failureheart failure with normal ejection fraction

Identifiers

PMID32341787
PMCPMC7174028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.